Insight

Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer

Paolo Ciracì/LinkedIn

Nov 20, 2024, 19:12

Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer

A recent paper by Paolo Ciracì, Medical Oncology Resident at the University Hospital of Pisa, was mentioned by Nieves Martinez Lago, Medical Oncologist at the University Hospital Complex of Ferrol, on X:

“Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm

FTD/TPI+BEV, REG and FRU for unselected patients.
Targeted Therapies for patients With Oncogenic Driver Molecular Alterations.
Rechallenge antiEGFR in patients ctDNA RAS/BRAF wild-type.”

“Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm”

Authors: Paolo Ciracì, Vittorio Studiale, Ada Taravella, Carlotta Antoniotti, Chiara Cremolini.

For more posts like this, visit oncodaily.com.

Ada Taravella cancer Carlotta Antoniotti Chiara Cremolini clinical trials Metastatic colorectal cancer Nieves Martinez Lago OncoDaily Oncology Paolo Ciracì Vittorio Studiale

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage